Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Sonova Holding AG (SONVY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
78.08+0.48 (+0.62%)
At close: 3:57PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close77.60
Open77.52
Bid0.00 x 0
Ask0.00 x 0
Day's Range77.45 - 78.08
52 Week Range46.75 - 83.62
Volume5,143
Avg. Volume33,865
Market Cap24.612B
Beta (5Y Monthly)0.76
PE Ratio (TTM)39.28
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.69 (0.89%)
Ex-Dividend DateJun 17, 2021
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for SONVY

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • SONOVA HOLDING AG
    Analyst Report: Coloplast A/SColoplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy-care systems, disposable containment devices, paste, powder, seals, and wipes. Coloplast also maintains a tertiary presence in the urology and wound-care markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.
    Rating
    Fair Value
    Economic Moat
    19 days agoMorningstar
View more
  • We're sorry we weren't able to find anything about this topic.

Advertisement
Advertisement